Publications

• Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape?
  Haemophilia Volume: 30 Suppl 3 Page(s): 95 - 102
  04/01/2024 Authors: Meeks SL; Zimowski KL
• Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework.
  J Thromb Haemost Volume: 22 Page(s): 645 - 665
  03/01/2024 Authors: Ross JE; Mohan S; Zhang J; Sullivan MJ; Bury L; Lee K; Futchi I; Frantz A; McDougal D; Perez Botero J
• Procedural outcomes in children with mild type 1 von Willebrand disease.
  Res Pract Thromb Haemost Volume: 8 Page(s): 102334
  01/01/2024 Authors: Heery S; Zimowski K; Mason SF; White MH; DiGiandomenico S; Trotter C; Sidonio RF; Brown MC
• Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
  J Cardiothorac Vasc Anesth Volume: 36 Page(s): 724 - 727
  03/01/2022 Authors: Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
• F5-Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV-short production.
  J Thromb Haemost Volume: 19 Page(s): 1653 - 1665
  07/01/2021 Authors: Zimowski KL; Petrillo T; Ho MD; Wechsler J; Shields JE; Denning G; Jhita N; Rivera AA; Escobar MA; Kempton CL
• Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency.
  J Thromb Haemost Volume: 18 Page(s): 2551 - 2556
  10/01/2020 Authors: Zimowski KL; McGuinn CE; Abajas YL; Schultz CL; Kaicker S; Batsuli G
• TFPI blockade: removing coagulation's brakes.
  Blood Volume: 134 Page(s): 1885 - 1887
  11/28/2019 Authors: Sidonio RF; Zimowski KL
• Severe Bleeding Events in Hemophilia. Patients Receiving Emicizumab Prophylaxis
  Volume: 134
  11/13/2019 Authors: Zimowski KL; Batsuli GM; Bryant P; McDaniel J; Tickle K; Meeks SL; Sidonio RF
• Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis.
  Haemophilia Volume: 25 Page(s): 789 - 796
  09/01/2019 Authors: Batsuli G; Zimowski KL; Tickle K; Meeks SL; Sidonio RF
• Factor II, Factor V, and Factor X Deficiencies
  Page(s): 699 - 702
  01/01/2019 Authors: Zimowski KL; Meeks SL
• Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis
  Volume: 132
  11/29/2018 Authors: Zimowski KL; Batsuli GM; Reding MT; Rana J; Callaghan MU; Tickle K; Meeks SL; Sidonio RF
• Bioengineering Gene Therapy Vectors for Hemophilia A Through Ancestral Sequence Reconstruction
  Volume: 25 Page(s): 43 - 44
  05/01/2017 Authors: Brown HC; Zimowski KL; Knight K; Zakas PM; Lillicrap D; Spencer HT; Doering CB
• Role of motif III in catalysis by acetyl-CoA synthetase.
  Archaea Volume: 2012 Page(s): 509579
  01/01/2012 Authors: Ingram-Smith C; Thurman JL; Zimowski K; Smith KS
• P wave changes during transient bradyarrhythmias in very low birth weight infants.
  Volume: 55 Page(s): S306 - S306
  01/01/2007 Authors: Zimowski K; Gamble Y; Mathew OP
• A unique, stressed-induced Ap(3)A hydrolase activity present on the cell surface of bovine aortic endothelial cells
  Volume: 18 Page(s): C12 - C12
  05/14/2004 Authors: Haghiac M; Zimowski K; Owen A; Hilderman R